These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 18519236

  • 1. The effect of tyrosine kinase inhibitors, tyrphostins: AG1024 and SU1498, on autocrine growth of prostate cancer cells (DU145).
    Kisielewska J, Ligeza J, Klein A.
    Folia Histochem Cytobiol; 2008; 46(2):185-91. PubMed ID: 18519236
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of tyrphostins AG494 and AG1478 on the autocrine growth regulation of A549 and DU145 cells.
    Bojko A, Reichert K, Adamczyk A, Ligęza J, Ligęza J, Klein A.
    Folia Histochem Cytobiol; 2012 Jul 05; 50(2):186-95. PubMed ID: 22763976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of vanadyl sulphate (VOSO4) on autocrine growth of human epithelial cancer cell lines.
    Holko P, Ligeza J, Kisielewska J, Kordowiak AM, Klein A.
    Pol J Pathol; 2008 Jul 05; 59(1):3-8. PubMed ID: 18655364
    [Abstract] [Full Text] [Related]

  • 10. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
    Takaoka S, Iwase M, Uchida M, Yoshiba S, Kondo G, Watanabe H, Ohashi M, Nagumo M, Shintani S.
    Int J Oncol; 2007 Jun 05; 30(6):1469-76. PubMed ID: 17487368
    [Abstract] [Full Text] [Related]

  • 11. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
    Patra N, De U, Kim TH, Lee YJ, Ahn MY, Kim ND, Yoon JH, Choi WS, Moon HR, Lee BM, Kim HS.
    Biomed Pharmacother; 2013 Jun 05; 67(5):407-15. PubMed ID: 23583193
    [Abstract] [Full Text] [Related]

  • 12. TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor.
    El-Obeid A, Hesselager G, Westermark B, Nistér M.
    Biochem Biophys Res Commun; 2002 Jan 11; 290(1):349-58. PubMed ID: 11779176
    [Abstract] [Full Text] [Related]

  • 13. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
    Seth D, Shaw K, Jazayeri J, Leedman PJ.
    Br J Cancer; 1999 May 11; 80(5-6):657-69. PubMed ID: 10360641
    [Abstract] [Full Text] [Related]

  • 14. A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.
    Xu X, Kreye E, Kuo CB, Walker AM.
    Cancer Res; 2001 Aug 15; 61(16):6098-104. PubMed ID: 11507059
    [Abstract] [Full Text] [Related]

  • 15. Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands.
    Carrión-Salip D, Panosa C, Menendez JA, Puig T, Oliveras G, Pandiella A, De Llorens R, Massaguer A.
    Int J Oncol; 2012 Sep 15; 41(3):1128-38. PubMed ID: 22684500
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells.
    Mimeault M, Moore E, Moniaux N, Hénichart JP, Depreux P, Lin MF, Batra SK.
    Int J Cancer; 2006 Feb 15; 118(4):1022-31. PubMed ID: 16108016
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells.
    Pu YS, Hsieh MW, Wang CW, Liu GY, Huang CY, Lin CC, Guan JY, Lin SR, Hour TC.
    Biochem Pharmacol; 2006 Mar 14; 71(6):751-60. PubMed ID: 16413505
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of prostate cancer cell growth by human secreted PDZ domain-containing protein 2, a potential autocrine prostate tumor suppressor.
    Tam CW, Cheng AS, Ma RY, Yao KM, Shiu SY.
    Endocrinology; 2006 Nov 14; 147(11):5023-33. PubMed ID: 16873542
    [Abstract] [Full Text] [Related]

  • 19. EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer.
    Huether A, Höpfner M, Baradari V, Schuppan D, Scherübl H.
    Biochem Pharmacol; 2005 Nov 25; 70(11):1568-78. PubMed ID: 16226226
    [Abstract] [Full Text] [Related]

  • 20. The depletion of cellular ATP by AG2034 mediates cell death or cytostasis in a hypoxanthine-dependent manner in human prostate cancer cells.
    Obajimi O, Melera PW.
    Cancer Chemother Pharmacol; 2008 Jul 25; 62(2):215-26. PubMed ID: 17896107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.